blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2229434

EP2229434 - DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.07.2012
Database last updated on 14.09.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Lifescan, Inc.
1000 Gibraltar Drive
Milpitas, CA 95035 / US
[2010/38]
Inventor(s)01 / REZANIA, Alireza
5 Dewitt Lane
Hillsborough, New Jersey 08844 / US
 [2010/38]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2011/36]Carpmaels & Ransford
One Southampton Row London
WC1B 5HA / GB
Former [2010/38]Carpmaels & Ransford
One Southampton Row London
WC1B 5HA / GB
Application number, filing date08855258.325.11.2008
[2010/38]
WO2008US84705
Priority number, dateUS20070990529P27.11.2007         Original published format: US 990529 P
[2010/38]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009070592
Date:04.06.2009
Language:EN
[2009/23]
Type: A2 Application without search report 
No.:EP2229434
Date:22.09.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 04.06.2009 takes the place of the publication of the European patent application.
[2010/38]
Type: B1 Patent specification 
No.:EP2229434
Date:07.09.2011
Language:EN
[2011/36]
Search report(s)International search report - published on:EP15.10.2009
ClassificationIPC:C12N5/07
[2011/36]
CPC:
C12N5/0676 (EP,US); C12N5/0678 (US); A61P1/18 (EP);
C12N2501/105 (EP,US); C12N2501/117 (EP,US); C12N2501/12 (EP,US);
C12N2501/15 (US); C12N2501/155 (EP,US); C12N2501/16 (EP,US);
C12N2501/335 (EP,US); C12N2501/385 (EP,US); C12N2501/40 (US);
C12N2501/41 (EP,US); C12N2501/415 (EP,US); C12N2501/42 (EP,US);
C12N2501/70 (EP,US); C12N2501/727 (US); C12N2501/998 (EP,US);
C12N2501/999 (EP,US); C12N2506/02 (EP,US); C12N2533/90 (EP,US) (-)
Former IPC [2010/38]C12N5/08
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/38]
TitleGerman:DIFFERENZIERUNG MENSCHLICHER EMBRYONALER STAMMZELLEN[2010/38]
English:DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS[2010/38]
French:DIFFÉRENTIATION DES CELLULES SOUCHES EMBRYONNAIRES HUMAINES[2010/38]
Entry into regional phase25.06.2010National basic fee paid 
25.06.2010Designation fee(s) paid 
25.06.2010Examination fee paid 
Examination procedure25.06.2010Examination requested  [2010/38]
20.08.2010Amendment by applicant (claims and/or description)
04.02.2011Communication of intention to grant the patent
08.06.2011Fee for grant paid
08.06.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.02.2011
Opposition(s)11.06.2012No opposition filed within time limit [2012/33]
Fees paidRenewal fee
12.11.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
HR07.09.2011
HU07.09.2011
LT07.09.2011
LV07.09.2011
MT07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
TR07.09.2011
IE25.11.2011
LU25.11.2011
MC30.11.2011
BG07.12.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
[2013/45]
Former [2013/44]CY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
MT07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
TR07.09.2011
IE25.11.2011
LU25.11.2011
MC30.11.2011
BG07.12.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2013/29]CY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
MT07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
IE25.11.2011
LU25.11.2011
MC30.11.2011
BG07.12.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2013/25]CY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
MT07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
IE25.11.2011
LU25.11.2011
MC30.11.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2013/14]CY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
MT07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
IE25.11.2011
MC30.11.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2012/47]CY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
IE25.11.2011
MC30.11.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2012/35]CY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
MC30.11.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2012/29]CY07.09.2011
CZ07.09.2011
EE07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
MC30.11.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2012/26]CY07.09.2011
CZ07.09.2011
EE07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2012/23]CY07.09.2011
CZ07.09.2011
EE07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2012/21]CY07.09.2011
CZ07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
SE07.09.2011
SI07.09.2011
NO07.12.2011
GR08.12.2011
IS07.01.2012
Former [2012/13]CY07.09.2011
FI07.09.2011
HR07.09.2011
LT07.09.2011
LV07.09.2011
SE07.09.2011
SI07.09.2011
NO07.12.2011
GR08.12.2011
Cited inInternational search[X]US2003138948  (FISK GREGORY J [US], et al) [X] 1-102 * paragraph [0067]; table 1 *;
 [X]WO2005116073  (NOVOCELL INC [US], et al) [X] 1-102 * figure 1; claims 29-67 *;
 [A]WO2006016999  (NOVOCELL INC [US], et al) [A] 1 * page 2 - page 5; figure 1 *;
 [XD]  - SKOUDY A ET AL, "Transforming growth factor (TGF)beta, fibroblast growth factor (FGF) and retinoid signalling pathways promote pancreatic exocrine gene expression in mouse embryonic stem cells", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, (20040501), vol. 379, no. Pt 3, ISSN 0264-6021, pages 749 - 756, XP002365298 [XD] 1-102 * the whole document *

DOI:   http://dx.doi.org/10.1042/BJ20031784
 [A]  - KUBO A ET AL, "Development of definitive endoderm from embryonic stem cells in culture", DEVELOPMENT, COMPANY OF BIOLOGISTS, CAMBRIDGE, GB, (20040401), vol. 131, no. 7, ISSN 0950-1991, pages 1651 - 1662, XP002985523 [A] 1 * page 1652, column RHC, paragraph 1 *

DOI:   http://dx.doi.org/10.1242/dev.01044
 [DA]  - MICALLEF S J ET AL, "Retinoic acid induces Pdx1-positive endoderm in differentiating mouse embryonic stem cells", DIABETES, AMERICAN DIABETES ASSOCIATION, US, (20050201), vol. 54, no. 2, ISSN 0012-1797, pages 301 - 305, XP002364807 [DA] 1 * the whole document *

DOI:   http://dx.doi.org/10.2337/diabetes.54.2.301
 [XD]  - D'AMOUR K A ET AL, "Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20060101), vol. 24, no. 11, ISSN 1087-0156, pages 1392 - 1401, XP002423119 [XD] 1-51 * figure 1 *

DOI:   http://dx.doi.org/10.1038/nbt1259
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.